However, validation studies of these models in different populations revealed a lack of sensitivity.28–30 Arguably, including biomarkers such as MR-proANP and CT-proET1 in these established clinical ROP prediction models may improve their predictive value and their sensitivity. Here, NR3C2 is linked to retinopathy of prematurity.